Ronald J. Daniels, a director at BridgeBio Pharma, Inc. ($BBIO), sold shares on the open market once in the last 365 days for nearly $3.9 million, with the most recent sale on November 6, 2025. His total sales rank in 2,287th place among 11,678 individual insiders, below the average sale amount of $8.59 million across 6.37 transactions. Daniels made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Director | M | Common Stock | 61031 | $34.65 | 78,022.0000 | 192,708,813 | 359.20% | 0.03% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Director | S | Common Stock | 61031 | $63.72 | 16,991.0000 | 192,708,813 | 78.22% | 0.03% |
| Nov. 6, 2025 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Director | M | Stock Option (Right to Buy) | 61031 | $0.00 | 30,523.0000 | 192,708,813 | 66.66% | 0.03% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Not found | A | Common Stock | 6589 | $0.00 | 16,991.0000 | 190,188,626 | 63.34% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | DANIELS RONALD J | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |